References
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med. 1995;333:1581–1588.
- Neuwelt E, Abbott NG, Abrey L, et al. Strategies to advance translational research into brain barriers. Lancet Neurol. 2008;7:84–96.
- Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. Neurotherapeutics 2005;2:3–14.
- Wang C, Cheng L, Liu Z. Drug delivery with upconversion nanoparticles for multi functional targeted cancer cell imaging and therapy. Biomaterials 2011;32:1110–1120.
- Lu RM, Chang YL, Chen MS, et al. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials 2011;32:265–274.
- Orive G, Anitua E, Pedraz JL, et al. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci. 2009;10:682–692.
- Liu L, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG TAT for drug delivery across the blood-brain barrier. Biomaterials 2008;29:1509–1517.
- Geim AK, Novoselov KS. The rise of grapheme. Nature Mater. 2007;6:183–191.
- Akhavan O, Ghaderi E, Rahighi R. Toward single-DNA electrochemical biosensing by graphene nanowalls. ACS Nano. 2012;6:2904–2916.
- Lee C, Wei X, Kysar JW, et al. Measurement of the elastic properties and intrinsic strength of monolayer grapheme. Science 2008;321:385–388.
- Mohanty N, Berry V. Graphene-based single-bacterium resolution bio-device and DNA transistor interfacing graphene derivatives with nanoscale and microscale biocomponents. Nano Lett. 2008;8:4469–4476.
- Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4:5731–5736.
- Akhavan O, Ghaderi E. Escherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting manner. Carbon 2012;50:1853–1860.
- Akhavan O, Ghaderi E, Esfandiar A. Wrapping bacteria by graphene nanosheets for isolation from environment, reactivation by sonication, and inactivation by near-infrared irradiation. J Phys Chem B. 2011;115:6279–6288.
- Akhavan O, Choobtashani M, Ghaderi E. Protein degradation and RNA efflux of viruses photocatalyzed by graphene tungsten oxide composite under visible light irradiation. J Phys Chem C. 2012;116:9653–9659.
- Robinson JT, Tabakman SM, Liang Y, et al. Ultrasmall reduced grapheme oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011;133:6825–6831.
- Yang K, Wan J, Zhang S, et al. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012;33:2206–2214.
- Yang K, Zhang S, Zhang G, et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10:3318–3323.
- Yang K, Hu L, Ma X, et al. Multimodel imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater. 2012;24:1868–1872.
- Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1:203–212.
- Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010;6:537–544.
- Bussy C, Ali-Boucetta H, Kostarelos K. Safety considerations for graphene: lessons learnt from carbon nanotubes. Acc Chem Res. 2013;46:692–701.
- Shih CJ, Lin S, Sharma R, et al. Understanding the pH-dependent behavior of graphene oxide aqueous solutions: a comparative experimental and molecular dynamics simulation study. Langmuir 2012;28:235–241.
- Eizenberg M, Blakely JM. Carbon monolayer phase condensation on Ni (111). Surf Sci. 1979;82:228–236.
- Bagri A, Mattevi C, Acik M, et al. Structural evolution during the reduction of chemically derived graphene oxide. Nature Chem. 2010;2:581–587.
- Park S, Ruoff RS. Chemical methods for the production of graphenes. Nat Nanotechnol. 2009;4:217–224.
- Stankovich S, Dikin DA, Piner RD, et al. Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 2007;45:1558–1565.
- Wang G, Yang J, Park J, et al. Facile synthesis and characterization of graphene nanosheets. J Phys Chem C. 2008;112:8192–8195.
- Si Y, Samulski ET, Hill C, et al. Synthesis of water soluble graphene. Nano Lett. 2008;8:1679–1682.
- Paredes JI, Villar-Rodil S, Fernandez-Merino MJ, et al. Environmentally friendly approaches toward the mass production of processable graphene from graphite oxide. J Mater Chem. 2011;21:298–306.
- Maddinedi SB, Mandal BK. Biofabrication of reduced graphene oxide nanosheets using Terminalia bellirica fruit extract. Current Nanosci. 2015;12:94–102.
- Farnosh T, Masoud SN, Fatemeh M. Green synthesis of flower-like CuI microstructures composed of trigonal nanostructures using pomegranate juice. Mater Lett. 2013;100:133–136.
- Farnosh T, Masoud SN, Davood G, et al. Application of glucose as a green capping agent and reductant to fabricate CuI micro/nanostructures. Mater Res Bull. 2014;49:14–20.
- Samira M, Faezeh S, Masoud SN. Sol–gel auto combustion synthesis of BaFe12O19nanoceramics by using carbohydrate sugars as a novel reducing agent. Adv Powder Technol. 2015;26:1348–1354.
- Farnosh T, Masoud SN, Alireza B, et al. Green synthesis and characterization of graphene nanosheets. Mater Res Bull. 2015;63:51–57.
- Maddinedi SB, Mandal BK, Vankayala R, et al. Bioinspired reduced graphene oxide nanosheets using Terminalia chebula seeds extract. Spectrochim Acta A Mol Biomol Spectrosc. 2015;145:117–124.
- Han F, Chen YX, Lu YM, et al. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res. 2011;51:124–135.
- Lu YM, Tao RR, Huang JY, et al. P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand. J Neuroinflamm. 2012;9:172.
- Lee JS, Joung H, Kim M, et al. Graphene-based chemiluminescence resonance energy transfer for homogeneous immunoassay. ACS Nano. 2012;6:2978–2983.
- Hosseini S, Ibrahim F, Djordjevic I, et al. Synthesis and processing of ELISA polymer substitute: the influence of surface chemistry and morphology on detection sensitivity. Appl Surf Sci. 2014;317:630–638.
- Jean-Laurent C, Lionel JV, Chahrazad M. Sevoflurane preconditioning against focal cerebral ischemia. Anesthesiology 2009;110:1271–1278.
- Shioda N, Han F, Moriguchi S, et al. Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J Neurochem. 2007;102:1506–1517.
- Lu RM, Chang YL, Chen MS, et al. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials 2011;32:3265–3274.
- Zhang GS, Tian Y, Huang JY, et al. Theg-Secretase blocker DAPT reduces the permeability of the blood-brain barrier by decreasing the ubiquitination and degradation of occluding during permanent brain ischemia. CNS Neurosci Ther. 2013;19:53–60.
- Tai SH, Chen HY, Lee EJ, et al. Melatonin inhibits post ischaemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res. 2010;49:332–341.